Alterations in Antibody Subclass Immune Reactivity to Trophoblast-derived Fetal Fibronectin and α2-Macroglobulin in Women with Recurrent Pregnancy Loss

American Journal of Reproductive Immunology

Volumn 68, Issue 5, 2012, Pages 438-449

  Saunders, Rhiana D ^a   Nakajima, Steven T ^a   Rai, Shesh N ^b   Pan, Jianmin ^b   Gercel Taylor, Cicek ^a   Taylor, Douglas D ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Antibody reactivity; Humoral immunity; Recurrent pregnancy loss; Trophoblast

Indexed keywords

ALPHA 2 MACROGLOBULIN; FIBRONECTIN; IMMUNOGLOBULIN G3 ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; PRIORITY JOURNAL; RECURRENT ABORTION; TROPHOBLAST; WESTERN BLOTTING;

ABORTION, HABITUAL; ADULT; ALPHA-MACROGLOBULINS; AUTOANTIBODIES; DECIDUA; FEMALE; FIBRONECTINS; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TROPHOBLASTS; YOUNG ADULT;

EID: 84867467619     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01182.x     Document Type: Article

References (41)

1. Stirrat GM: Recurrent miscarriage. Lancet 1990; 336:673-675.
2. Christiansen OB, Andersen AN, Bosche E, Daya S, Delves P, Hviid T, Kutteh W, Laird S, Li T, van der Ven K: Evidence based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005; 83:821-839.
3. Practice Committee of the American Society for Reproductive Medicine: Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008; 90:S60.
4. ACOG Practice Bulletin No 24: Management of recurrent early pregnancy loss. Obstet Gynecol 2001; 97:1-12.
5. Szekeres-Bartho J, Balasch J: Progestogen therapy for recurrent miscarriage. Hum Reprod Update 2008; 14:27-35.
6. Hamilton RG: Human IgG subclass measurements in the clinical laboratory. Clin Chem 1987; 33:1707-1725.
7. Bruggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger MS: Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 1987; 166:1351-1361.
8. Greenwood J, Clark M: Effector functions of matched sets pf recombinant human IgG subclass antibodies. 1993.
9. Torry DS, McIntyre JA, McConnachie PR: Characterization of immunoglobulin class and subclass responses in secondary aborter sera. J Reprod Immunol 1987; 10:33-42.
10. Meulenbroek AJ, Zeijlemaker WP: Human IgG Subclasses: useful diagnostic markers for immunocompetence. Sanquin. www.Sanquin.nl
11. Smith SL: Ten years of Orthoclone OKT3 (muromonab-CD3): a review. J Transpl Coord 1996; 6:109-119.
12. Wilson R, Maclean M, Jenkins C, Kinnane D, Mooney J, Walker J: Abnormal immunoglobulin subclass patterns in women with a history of recurrent miscarriage. Fertil Steril 2001; 76:915-917.
13. Eblen AC, Gercel-Taylor C, Shields LB, Sanfilippo JS, Nakajima ST, Taylor DD: Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil Steril 2000; 73:305-313.
14. Saunders R: Alterations of antibody subclass immune responses and trophoblast antigens recognised in women with recurrent pregnancy loss. Poster session conducted at the ASRM 66th annual Meeting, 2010.
15. Harger JH, Archer DF, Marchese SG, Muracca-Clemens M, Garver K: Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol 1983; 62:574.
16. Devi Wold AS, Pham N, Arici A: Anatomic factors in recurrent pregnancy loss. Semin Reprod Med 2006; 24:25.
17. Reindollar RH: Contemporary issues for spontaneous abortion. Does recurrent abortion exist? Obstet Gynecol Clin North Am 2000; 27:541.
18. Miller E, Hare JW, Cloherty JP, Dunn P, Gleason R, Soeldner J, Kitzmiller J: Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants and diabetic mothers. N Eng J Med 1981; 304:1331.
19. Clifford K, Rai R, Watson H, Regan L: An informative protocol for the investigation of recurrent miscarriage: a preliminary experience of 500 consecutive cases. Human Reprod 1998; 13:1471-1479.
20. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter T, Luthy D, Gross S, Bianchi D, D'Alton M: Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112:85.
21. Bianco K, Caughey AB, Shaffer BL, Davis R, Norton M: History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy. Obstet Gynecol 2006; 107:1098.
22. Trout SW, Seifer DB: Do women with unexplained recurrent pregnancy loss have higher day 3 FSH and estradiol values? Fertil Steril 2000; 74:335.
23. Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: a metaanalysis. Lancet 2003; 361:901-908.
24. Kovalski G, Garcia CR, Berlin JA, Sammel MD, Barnhart KT: Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 2004; 164:558-563.
25. Visser JA, de Jong FH, Laven JS, Themmen AP: Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 2006; 131:1-9.
26. Seifer DB, Maclaughlin DT: Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil Steril 2007; 88:539-546.
27. Straszewski-Chavez SL, Abrahams VM, Alvero AB, Aldo PB, Ma Y, Guller S, Romero R, Mor G: The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta 2009; 30:939-948.
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
29. McCullagh P, Nelder JA: Generalized Linear Models, 2nd edn. Boca Raton, Chapman and Hall, 1989.
30. Creus M, Balasch J, Fabregues F, Martorell J, Boada M, Penarrubia J, Barri P, Vanrell J: Parental human leukocyte antigens and implantation failure after in vitro fertilization. Hum Reprod 1998; 13:39-43.
31. Esadeg S, He H, Pijnenborg R, Van Leuven F, Croy BA: Alpha-2 macroglobulin controls trophoblast positioning in mouse implantation sites. Placenta 2003; 24:912-921.
32. Shimizu M, Jinbo T, Kashiwazaki N, Kuribayashi T, Nomura M, Yamamoto S: Transplacental transport of alpha 2-macroglobulin (alpha 2M) and induction of alpha 2M in maternal and neonatal rats with acute inflammation. Exp Anim 2002; 51:361-365.
33. Jensen PH, Moestrup SK, Sottrup-Jensen L, Petersen CM, Gliemann J: Receptors for alpha 2-macroglobulin- and pregnancy zone protein-proteinase complexes in the human placental syncytiotrophoblast. Placenta 1988; 9:463-477.
34. Thomas T, Southwell BR, Schreiber G, Jaworowski A: Plasma protein synthesis and secretion in the visceral yolk sac of the fetal rat: gene expression, protein synthesis and secretion. Placenta 1990; 11:413-430.
35. Benyo DF, Little-Ihrig L, Zeleznik AJ: Noncoordinated expression of luteal cell messenger ribonucleic acids during human chorionic gonadotropin stimulation of the primate corpus luteum. Endocrinology 1993; 133:699-704.
36. Guller S. Fetal membranes: anatomy and biochemistry. Up-To-Date 17.3, 2009.
37. Mercorio F, Mercorio A, Di Spiezio Sardo A, Votino C, Barba GV, Nappi C: Cervical fetal fibronectin as a predictor of first trimester pregnancy outcome in unexplained recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 2006; 126:165-169.
38. Roman J, Ritzenthaler JD, Fenton MJ, Roser S, Schuyler W: Transcriptional regulation of the human interleukin 1b gene by fibronectin: Role of protein kinase C and activation protein 1 (AP-1). Cytokine 2000; 12:1581-1596.
39. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M: Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 2007; 114:134-142.
40. Stevenson MD, Kutteh WH, Purkiss S, Librach C, Schulz P, Houlihan E, Liao C: Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010; 25:2203-2209.
41. Stricker RB, Winger EE: Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin. Am J Reprod Immunol 2005; 54:390-396.